| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
Form 4: Gallman Cari, EVP, General Counsel
Received 4,559 shares by exercise or conversion · Gave up 2,332 shares to cover exercise price or tax ($143K) |
| 02 Oct 2026 |
Form 4: Samuels Theodore R. Ii, Director
Granted 821.314 Deferred Share Units ($51.2K) |
| 02 Oct 2026 |
Form 4: McMullen Michael R., Director
Granted 560.897 Deferred Share Units ($35K) |
| 02 Oct 2026 |
Form 4: Rice Derica W, Director
Granted 620.994 Deferred Share Units ($38.8K) |
| 02 Oct 2026 |
Form 4: Arduini Peter J, Director
Granted 560.897 Deferred Share Units ($35K) |
| 02 Oct 2026 |
Form 4: Yale Phyllis R, Director
Granted 560.897 Deferred Share Units ($35K) |
| 10 Sep 2026 |
Form 4: Massacesi Cristian, EVP,Chief Med Offr,Head of Dev
Sold 6,249 shares ($403K) |
| 09 Sep 2026 | 144 |
| 03 Sep 2026 |
Form 4: Short Bartie Wendy, EVP, Corporate Affairs
Received 1,236 shares by exercise or conversion ($82.7K) · Gave up 633 shares to cover exercise price or tax ($42.4K) |
| 26 Aug 2026 |
Form 4: Holzer Phil M, SVP and Controller
Sold 500 shares ($33.8K) |
| 25 Aug 2026 | 144 |
| 07 Aug 2026 | SCHEDULE 13G |
| 04 Aug 2026 |
Form 4: Massacesi Cristian, EVP,Chief Med Offr,Head of Dev
Received 51,172 shares by exercise or conversion · Gave up 26,175 shares to cover exercise price or tax ($1.71M) |
| 04 Aug 2026 |
Form 4: Gallman Cari, EVP, General Counsel
Received 1,061 shares by exercise or conversion · Gave up 543 shares to cover exercise price or tax ($35.5K) |
| 30 Jul 2026 | 10-Q |
| 30 Jul 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 02 Jul 2026 |
Form 4: Yale Phyllis R, Director
Granted 607.428 Deferred Share Units ($35K) |
| 02 Jul 2026 |
Form 4: Samuels Theodore R. Ii, Director
Granted 889.448 Deferred Share Units ($51.2K) |
| 02 Jul 2026 |
Form 4: Rice Derica W, Director
Granted 672.51 Deferred Share Units ($38.8K) |
| 02 Jul 2026 |
Form 4: McMullen Michael R., Director
Granted 607.428 Deferred Share Units ($35K) |
Loading...